Nutrient quality
Conventional oral delivery does not overcome the main uncertainty about how much ordinary GABA reaches the brain. upper-range falls within a practical standalone range.
Vitacost | $ 18.98 | |
| $ 18.98 | ||
Walmart | $ 22.07 |
750 mg sits within a practical standalone range for a product aimed at relaxation, stress, or sleep support. Oral GABA targets an inhibitory pathway, but its ability to reach the brain reliably remains uncertain.
Capsule delivery is simple and provides a fixed serving. The single-active design is easy to assess and avoids unrelated ingredients.
Very low serving cost and a generous supply support economical regular use. The formula is better suited to situational calming than to broad mood support or circadian sleep timing.
Conventional oral delivery does not overcome the main uncertainty about how much ordinary GABA reaches the brain. upper-range falls within a practical standalone range.
The GABA amount is clearly disclosed. Excipients and daily directions are absent from the supplied data, which leaves some label details uncertain.
The aggregate satisfaction average is strong, though no detailed feedback is supplied. The substantial volume provides a useful aggregate satisfaction signal.
A clear, practical amount supports good formula value despite generic sourcing. The serving cost is exceptionally low for the disclosed amount.
GABA at 750 mg directly targets inhibitory signaling associated with relaxation and reduced nervous-system arousal. The single-capsule amount is substantial and clearly disclosed.
Human evidence for standard oral GABA crossing into the brain and consistently reducing stress is mixed. The dose may cause sleepiness in sensitive users, especially when combined with alcohol or other sedating products.
The standalone GABA dose is intended to support relaxation, but oral GABA has uncertain access to the brain. That limitation makes direct sleep benefits less dependable than those from more established circadian or mineral-based ingredients.
The capsule provides a clearly disclosed 750 mg amount with no proprietary blend. Sleepiness may occur in sensitive users, so the capsule should first be tried when alertness is not required afterward.
The 750 mg GABA amount is fully disclosed and may promote relaxation in some users. Oral GABA has limited access to the brain, so evidence for direct mood regulation remains weak.
The single-ingredient formula is clean but covers only an inhibitory-signaling pathway with uncertain central activity. The amount may cause sleepiness in sensitive users, making it poorly suited to tasks requiring alertness.
| Ingredient | Amount per serving |
|---|---|
GABA | 750 mg |
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.